Department of Gynecologic Oncology
Robert Morris has not added Biography.
If you are Robert Morris and would like to personalize this page please email our Author Liaison for assistance.
Alternate dosing schedules for topotecan in the treatment of recurrent ovarian cancer.
The oncologist , 2002 | Pubmed ID: 12324631
Weekly topotecan in the management of ovarian cancer.
Gynecologic oncology Sep, 2003 | Pubmed ID: 13129494
Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT).
Gynecologic oncology May, 2004 | Pubmed ID: 15099970
Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis.
American journal of clinical oncology Jun, 2004 | Pubmed ID: 15170144
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
Cancer research Jan, 2006 | Pubmed ID: 16424057
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Jan, 2007 | Pubmed ID: 17099695
Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.
Gynecologic oncology Dec, 2008 | Pubmed ID: 18289650
Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.
Gynecologic oncology Jun, 2008 | Pubmed ID: 18410954
Second neoplasms in survivors of endometrial cancer: impact of radiation therapy.
Gynecologic oncology May, 2009 | Pubmed ID: 19249081
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.
Molecular cancer , 2009 | Pubmed ID: 19386116
Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression.
Archives of gynecology and obstetrics Dec, 2010 | Pubmed ID: 20140681
Analysis of the expression of human tumor antigens in ovarian cancer tissues.
Cancer biomarkers : section A of Disease markers , 2010 | Pubmed ID: 20164540
Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Molecular cancer , 2010 | Pubmed ID: 20196847
Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer.
Archives of gynecology and obstetrics Feb, 2011 | Pubmed ID: 20383771
Ovarian cancer: relevant therapy, not timing, is paramount.
Lancet (London, England) Oct, 2010 | Pubmed ID: 20888975
Tumor autoantibodies as biomarkers for predicting ovarian cancer recurrence.
Cancer biomarkers : section A of Disease markers , 2012 | Pubmed ID: 23011153
Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.
Biomarker insights , 2012 | Pubmed ID: 23300341
Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Jul, 2013 | Pubmed ID: 23765206
Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.
Gynecologic oncology Feb, 2014 | Pubmed ID: 24262874
Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
Gynecologic oncology May, 2014 | Pubmed ID: 24561247
Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).
Annals of oncology : official journal of the European Society for Medical Oncology Apr, 2014 | Pubmed ID: 24667717
Dietary energy balance modulates ovarian cancer progression and metastasis.
Oncotarget Aug, 2014 | Pubmed ID: 25026276
Preface.
Cancer metastasis reviews Mar, 2015 | Pubmed ID: 25648358
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.
Oncotarget May, 2015 | Pubmed ID: 25895126
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology Dec, 2016 | Pubmed ID: 27692669
Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer.
Free radical biology & medicine Jan, 2017 | Pubmed ID: 27890641
Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-]pyrimidine Antifolates.
Molecular cancer therapeutics May, 2017 | Pubmed ID: 28138029
The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists Sep, 2017 | Pubmed ID: 28277313
Involvement and comfort of gynecologic oncologists in the treatment of pediatric, adolescent, and young adult patients with gynecologic malignancies.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Aug, 2017 | Pubmed ID: 28485838
Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality.
Free radical biology & medicine Sep, 2017 | Pubmed ID: 28499912
Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase.
Free radical biology & medicine Sep, 2017 | Pubmed ID: 28552694
Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists May, 2017 | Pubmed ID: 28727617
Dimercapto-1-propanesulfonic acid (DMPS) induces metaphase II mouse oocyte deterioration.
Free radical biology & medicine Nov, 2017 | Pubmed ID: 28844937
Melatonin prevents hypochlorous acid-mediated cyanocobalamin destruction and cyanogen chloride generation.
Journal of pineal research Apr, 2018 | Pubmed ID: 29247550
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Gynecologic oncology Mar, 2018 | Pubmed ID: 29329880
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology Jul, 2018 | Pubmed ID: 29778506
Acrolein, a commonly found environmental toxin, causes oocyte mitochondrial dysfunction and negatively affects embryo development.
Free radical research Sep, 2018 | Pubmed ID: 29886754
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance.
Cancer medicine Mar, 2019 | Pubmed ID: 30761774
Molecular Basis Supporting the Association of Talcum Powder Use With Increased Risk of Ovarian Cancer.
Reproductive sciences (Thousand Oaks, Calif.) Dec, 2019 | Pubmed ID: 30819054
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Gynecologic oncology Jul, 2019 | Pubmed ID: 31053405
Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Gynecologic oncology Sep, 2019 | Pubmed ID: 31248668
The inhibition of lactoperoxidase catalytic activity through mesna (2-mercaptoethane sodium sulfonate).
Journal of inorganic biochemistry Feb, 2020 | Pubmed ID: 31734539
Hypochlorous acid reversibly inhibits caspase-3: a potential regulator of apoptosis.
Free radical research Jan, 2020 | Pubmed ID: 31909639
Heat Shock Protein 60 (HSP60) Serves as a Potential Target for the Sensitization of Chemoresistant Ovarian Cancer Cells.
Reproductive sciences (Thousand Oaks, Calif.) Apr, 2020 | Pubmed ID: 32124395
Molecular Basis Supporting the Association of Talcum Powder Use with Increased Risk of Ovarian Cancer.
Reproductive sciences (Thousand Oaks, Calif.) Oct, 2020 | Pubmed ID: 32813198
Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma.
Gynecologic oncology Nov, 2020 | Pubmed ID: 32900500
Ovarian cancer modulates the immunosuppressive function of CD11bGr1 myeloid cells via glutamine metabolism.
Molecular metabolism Nov, 2021 | Pubmed ID: 34144215
Impact of positive cytology in uterine serous carcinoma: A reassessment.
Gynecologic oncology reports Aug, 2021 | Pubmed ID: 34345643
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Gynecologic oncology Nov, 2021 | Pubmed ID: 34548162
Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.
Minerva obstetrics and gynecology Apr, 2023 | Pubmed ID: 34825792
Molecular profiles of endometrial cancer tumors among Black patients.
Gynecologic oncology Jul, 2022 | Pubmed ID: 35490034
Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education.
Obstetrics and gynecology May, 2022 | Pubmed ID: 35576351
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2022 | Pubmed ID: 35759733
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.
Scientific reports Jul, 2022 | Pubmed ID: 35790779
Binding of Intracellular Myeloperoxidase to αV/β1 Integrin Serves as a Mechanism of Survival in Epithelial Ovarian Cancer.
Reproductive sciences (Thousand Oaks, Calif.) Jan, 2023 | Pubmed ID: 35799017
Decreased incidence of febrile neutropenia in Michigan following masking and social distancing orders for the COVID-19 pandemic: A population based cohort study.
World journal of clinical oncology Jul, 2022 | Pubmed ID: 36157163
The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists Sep, 2023 | Pubmed ID: 37131274
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.
Frontiers in immunology , 2023 | Pubmed ID: 37435088
A Novel Role of Connective Tissue Growth Factor in the Regulation of the Epithelial Phenotype.
Cancers Oct, 2023 | Pubmed ID: 37835529
Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals Dec, 2023 | Pubmed ID: 37982229
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados